Pt(IV)-M13

N/A

Report date: 2025/08/15 14:29:34
NME

Base Information

Drug NamePt(IV)-M13
Drug Alias NamePt(IV)-M13Pt(IV)-M-13
ClassificationSmall molecules > Synthetic peptide > Peptide drug conjugate (PDC)
Mechanisms of ActionDNA cross linking agentsDNA synthesis inhibitorsCell death stimulants
TargetsDNA
Therapy Area/IndicationsGlioblastoma
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesBrown University Cancer Center
China Registration ClassN/A

Develop Information

Active CompaniesBrown University Cancer Center
Inactive CompaniesN/A
Active IndicationsGlioblastoma
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A